Fulgent Genetics (FLGT) Change in Account Payables (2015 - 2026)

Fulgent Genetics has reported Change in Account Payables for 12 years, with the latest figure at -$3.4 million in Q2 2026.

• Quarterly Change in Account Payables fell 984.72% year-over-year to -$3.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3.0 million (down 350.5% YoY) and the FY2025 annual result came in at $550000.0, down 82.06% from the prior year.
• Change in Account Payables retreated to -$3.4 million in Q2 2026 per FLGT's latest filing, from -$408000.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $7.0 million in Q4 2022 and troughed at -$22.1 million in Q3 2022.
• A 5-year average of -$1.8 million and a median of -$326500.0 in 2024 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 318.23% in 2022, down 1860.21% in 2022.
• Over 5 years, Change in Account Payables stood at $7.0 million in 2022, then plunged by 98.16% to $129000.0 in 2023, then slumped by 726.36% to -$808000.0 in 2024, then soared by 214.36% to $924000.0 in 2025, then sank by 469.59% to -$3.4 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$3.4 million, -$408000.0, and $924000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.